231 related articles for article (PubMed ID: 7927229)
1. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis.
Lim AG; Jazrawi RP; Ahmed HA; Levy JH; Zuin M; Douds AC; Maxwell JD; Northfield TC
Hepatology; 1994 Oct; 20(4 Pt 1):882-8. PubMed ID: 7927229
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases.
Adams DH; Mainolfi E; Burra P; Neuberger JM; Ayres R; Elias E; Rothlein R
Hepatology; 1992 Sep; 16(3):810-4. PubMed ID: 1354635
[TBL] [Abstract][Full Text] [Related]
3. Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis.
Lim AG; Jazrawi RP; Levy JH; Petroni ML; Douds AC; Maxwell JD; Northfield TC
J Hepatol; 1995 Apr; 22(4):416-22. PubMed ID: 7545197
[TBL] [Abstract][Full Text] [Related]
4. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
Polzien F; Ramadori G
J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
[TBL] [Abstract][Full Text] [Related]
6. Soluble ICAM-1 (sICAM-1) in biliary atresia and its relationship to disease activity.
Minnick KE; Kreisberg R; Dillon PW
J Surg Res; 1998 Apr; 76(1):53-6. PubMed ID: 9695739
[TBL] [Abstract][Full Text] [Related]
7. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy.
Lim AG; Wolfhagen FH; Verma A; van Buuren HR; Jazrawi RP; Levy JH; Northfield TC; Schalm SW
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):155-61. PubMed ID: 9058626
[TBL] [Abstract][Full Text] [Related]
8. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Hultcrantz R; Scheynius A
Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
[TBL] [Abstract][Full Text] [Related]
9. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
10. Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity.
Douds AC; Lim AG; Jazrawi RP; Finlayson C; Maxwell JD
J Hepatol; 1997 Feb; 26(2):280-6. PubMed ID: 9059947
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
[TBL] [Abstract][Full Text] [Related]
12. Plasma antioxidant levels in chronic cholestatic liver diseases.
Floreani A; Baragiotta A; Martines D; Naccarato R; D'odorico A
Aliment Pharmacol Ther; 2000 Mar; 14(3):353-8. PubMed ID: 10735930
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules.
Nakanuma Y; Yasoshima M; Tsuneyama K; Harada K
Semin Liver Dis; 1997 Feb; 17(1):35-47. PubMed ID: 9089909
[TBL] [Abstract][Full Text] [Related]
14. Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination.
Fracchia M; Secreto P; Tabone M; Zaffino C; Pera A; Galatola G
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):463-8. PubMed ID: 10784002
[TBL] [Abstract][Full Text] [Related]
15. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes.
Thomson AW; Satoh S; Nüssler AK; Tamura K; Woo J; Gavaler J; van Thiel DH
Clin Exp Immunol; 1994 Jan; 95(1):83-90. PubMed ID: 7904546
[TBL] [Abstract][Full Text] [Related]
16. Detection of a soluble form of the human adhesion receptor lymphocyte function-associated antigen-3 (LFA-3) in patients with chronic liver disease.
Hoffmann JC; Bahr MJ; Tietge UJ; Braunstein J; Bayer B; Böker KH; Manns MP
J Hepatol; 1996 Oct; 25(4):465-73. PubMed ID: 8912145
[TBL] [Abstract][Full Text] [Related]
17. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Scheynius A; Hultcrantz R
Hepatology; 1993 Aug; 18(2):298-303. PubMed ID: 8340058
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of cholestatic liver disease].
Pleşa A
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
[TBL] [Abstract][Full Text] [Related]
19. Evidence of an increased nitric oxide production in primary biliary cirrhosis.
Battista S; Bar F; Mengozzi G; Pollet C; Torchio M; Cavalli G; Rosina F; David E; Cutrin JC; Cavalieri B; Poli G; Molino G
Am J Gastroenterol; 2001 Mar; 96(3):869-75. PubMed ID: 11280567
[TBL] [Abstract][Full Text] [Related]
20. Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis.
Ono M; Sekiya C; Ohhira M; Ohhira M; Namiki M; Endo Y; Suzuki K; Matsuda Y; Taniguchi N
J Lab Clin Med; 1991 Nov; 118(5):476-83. PubMed ID: 1682406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
